The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes

Journal of Experimental Medicine

Volumn 214, Issue 11, 2017, Pages 3293-3310

  Anzai, Atsushi ^a   Choi, Jennifer L ^a   He, Shun ^a   Fenn, Ashley M ^a   Nairz, Manfred ^a   Rattik, Sara ^a   McAlpine, Cameron S ^a   Mindur, John E ^a   Chan, Christopher T ^a   Iwamoto, Yoshiko ^a   Tricot, Benoit ^a   Wojtkiewicz, Gregory R ^a   Weissleder, Ralph ^a,b   Libby, Peter ^c   Nahrendorf, Matthias ^a   Stone, James R ^a   Becher, Burkhard ^d   Swirski, Filip K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD131 ANTIGEN; GELATINASE B; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; STAT5 PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; VIMENTIN; CHEMOKINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW; BONE MARROW CELL; CARDIOVASCULAR MAGNETIC RESONANCE; CELL INVASION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DEATH; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HEART FAILURE; HEART FIBROBLAST; HEART INFARCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE ISCHEMIA; HEART RUPTURE; HEMATOPOIESIS; HISTOLOGY; HUMAN; HUMAN CELL; LEUKOCYTE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; ANIMAL; C57BL MOUSE; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; MALE; METABOLISM; SURVIVAL ANALYSIS; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW; CHEMOKINES; CYTOKINE RECEPTOR COMMON BETA SUBUNIT; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INFLAMMATION; LEUKOCYTES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MONOCYTES; MYELOID CELLS; MYOCARDIAL INFARCTION; NEUTROPHILS; SURVIVAL ANALYSIS;

EID: 85033403618     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20170689     Document Type: Article

References (50)

1. Anzai, A., T. Anzai, S. Nagai, Y. Maekawa, K. Naito, H. Kaneko, Y. Sugano, T. Takahashi, H. Abe, S. Mochizuki, et al. 2012. Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation. 125:1234-1245. https ://doi.org /10.1161 /CIR CUL ATI ONA HA.111.052126
2. Becher, B., S. Tugues, and M. Greter. 2016. GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation. Immunity. 45:963-973. https ://doi.org /10.1016 /j.immuni.2016.10.026
3. Bradley, T.R., and D. Metcalf. 1966. The growth of mouse bone marrow cells in vitro. Aust. J. Exp. Biol. Med. Sci. 44:287-300. https ://doi.org /10.1038 /icb.1966.28
4. Brown, D.W., W.H. Giles, and J.B. Croft. 2001. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J. Clin. Epidemiol. 54:316-322. https ://doi.org /10.1016 /S0895-4356(00)00296-1
5. Bruno, S., B. Bussolati, P. Scacciatella, S. Marra, F. Sanavio, C. Tarella, and G. Camussi. 2006. Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. Cytokine. 34:56-65. https ://doi.org /10.1016 /j.cyto.2006.03.014
6. Dewald, O., P. Zymek, K. Winkelmann, A. Koerting, G. Ren, T. Abou-Khamis, L.H. Michael, B.J. Rollins, M.L. Entman, and N.G. Frangogiannis. 2005. CCL2/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts. Circ. Res. 96:881-889. https ://doi.org /10.1161 /01.RES.0000163017.13772.3a
7. Dutta, P., G. Courties, Y. Wei, F. Leuschner, R. Gorbatov, C.S. Robbins, Y. Iwamoto, B. Thompson, A.L. Carlson, T. Heidt, et al. 2012. Myocardial infarction accelerates atherosclerosis. Nature. 487:325-329. https ://doi.org /10.1038 /nature11260
8. Hajj-Ali, R., W. Zareba, R. Ezzeddine, and A.J. Moss. 2001. Relation of the leukocyte count to recurrent cardiac events in stable patients after acute myocardial infarction. Am. J. Cardiol. 88:1221-1224. https ://doi.org /10.1016 /S0002-9149(01)02080-X
9. Hamilton, J.A. 2008. Colony-stimulating factors in inflammation and autoimmunity. Nat. Rev. Immunol. 8:533-544. https ://doi.org /10.1038 /nri2356
10. Hamilton, J.A., A.D. Cook, and P.P. Tak. 2016. Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases. Nat. Rev. Drug Discov. 16:53-70. https ://doi.org /10.1038 /nrd.2016.231
11. Hayashidani, S., H. Tsutsui, T. Shiomi, M. Ikeuchi, H. Matsusaka, N. Suematsu, J. Wen, K. Egashira, and A. Takeshita. 2003. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation. 108:2134-2140. https ://doi.org /10.1161 /01.CIR.0000092890.29552.22
12. Heidt, T., G. Courties, P. Dutta, H.B. Sager, M. Sebas, Y. Iwamoto, Y. Sun, N. Da Silva, P. Panizzi, A.M. van der Laan, et al. 2014. Differential contribution of monocytes to heart macrophages in steady-state and after myocardial infarction. Circ. Res. 115:284-295. https ://doi.org /10.1161 /CIR CRE SAHA.115.303567
13. Heymans, S., A. Luttun, D. Nuyens, G. Theilmeier, E. Creemers, L. Moons, G.D. Dyspersin, J.P. Cleutjens, M. Shipley, A. Angellilo, et al. 1999. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat. Med. 5:1135-1142. https ://doi.org /10.1038 /13459
14. Hilgendorf, I., L.M. Gerhardt, T.C. Tan, C. Winter, T.A. Holderried, B.G. Chousterman, Y. Iwamoto, R. Liao, A. Zirlik, M. Scherer-Crosbie, et al. 2014a. Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ. Res. 114:1611-1622. https ://doi.org /10.1161 /CIR CRE SAHA.114.303204
15. Hilgendorf, I., I. Theurl, L.M. Gerhardt, C.S. Robbins, G.F. Weber, A. Gonen, Y. Iwamoto, N. Degousee, T.A. Holderried, C. Winter, et al. 2014b. Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity. Circulation. 129:1677-1687. https ://doi.org /10.1161 /CIR CUL ATI ONA HA.113.006381
16. Kaikita, K., T. Hayasaki, T. Okuma, W.A. Kuziel, H. Ogawa, and M. Takeya. 2004. Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am. J. Pathol. 165:439-447. https ://doi.org /10.1016 /S0002-9440(10)63309-3
17. Kempf, T., A. Zarbock, C. Widera, S. Butz, A. Stadtmann, J. Rossaint, M. Bolomini-Vittori, M. Korf-Klingebiel, L.C. Napp, B. Hansen, et al. 2011. GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice. Nat. Med. 17:581-588. https ://doi.org /10.1038 /nm.2354
18. Kyne, L., J.M. Hausdorff, E. Knight, L. Dukas, G. Azhar, and J.Y. Wei. 2000. Neutrophilia and congestive heart failure after acute myocardial infarction. Am. Heart J. 139:94-100. https ://doi.org /10.1016 /S0002-8703(00)90314-4
19. Leuschner, F., P. Panizzi, I. Chico-Calero, W.W. Lee, T. Ueno, V. Cortez-Retamozo, P. Waterman, R. Gorbatov, B. Marinelli, Y. Iwamoto, et al. 2010. Angiotensin-converting enzyme inhibition prevents the release of monocytes from their splenic reservoir in mice with myocardial infarction. Circ. Res. 107:1364-1373. https ://doi.org /10.1161 /CIR CRE SAHA.110.227454
20. Leuschner, F., P.J. Rauch, T. Ueno, R. Gorbatov, B. Marinelli, W.W. Lee, P. Dutta, Y. Wei, C. Robbins, Y. Iwamoto, et al. 2012. Rapid monocyte kinetics in acute myocardial infarction are sustained by extramedullary monocytopoiesis. J. Exp. Med. 209:123-137. https ://doi.org /10.1084 / jem.20111009
21. Madjid, M., I. Awan, J.T. Willerson, and S.W. Casscells. 2004. Leukocyte count and coronary heart disease: implications for risk assessment. J. Am. Coll. Cardiol. 44:1945-1956. https ://doi.org /10.1016 /j.jacc.2004.07.056
22. Maekawa, Y., T. Anzai, T. Yoshikawa, Y. Asakura, T. Takahashi, S. Ishikawa, H. Mitamura, and S. Ogawa. 2002. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling. J. Am. Coll. Cardiol. 39:241-246. https :// doi.org /10.1016 /S0735-1097(01)01721-1
23. Maekawa, Y., T. Anzai, T. Yoshikawa, Y. Sugano, K. Mahara, T. Kohno, T. Takahashi, and S. Ogawa. 2004. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J. Am. Coll. Cardiol. 44:1510-1520. https :// doi.org /10.1016 /j.jacc.2004.05.083
24. Mann, D.L. 2015. Innate immunity and the failing heart: the cytokine hypothesis revisited. Circ. Res. 116:1254-1268. https ://doi.org /10.1161 /CIR CRE SAHA.116.302317
25. Matsumura, S., S. Iwanaga, S. Mochizuki, H. Okamoto, S. Ogawa, and Y. Okada. 2005. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J. Clin. Invest. 115:599-609. https ://doi.org /10.1172 /JCI22304
26. Murphy, A.J., M. Akhtari, S. Tolani, T. Pagler, N. Bijl, C.L. Kuo, M. Wang, M. Sanson, S. Abramowicz, C. Welch, et al. 2011. ApoE regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J. Clin. Invest. 121:4138-4149. https ://doi.org /10.1172 /JCI57559
27. Nahrendorf, M., F.K. Swirski, E. Aikawa, L. Stangenberg, T. Wurdinger, J.L. Figueiredo, P. Libby, R. Weissleder, and M.J. Pittet. 2007. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204:3037-3047. https ://doi.org /10.1084 /jem.20070885
28. Nahrendorf, M., M.J. Pittet, and F.K. Swirski. 2010. Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation. 121:2437-2445. https ://doi.org /10.1161 /CIR CUL ATI ONA HA.109.916346
29. Panizzi, P., F.K. Swirski, J.L. Figueiredo, P. Waterman, D.E. Sosnovik, E. Aikawa, P. Libby, M. Pittet, R. Weissleder, and M. Nahrendorf. 2010. Impaired infarct healing in atherosclerotic mice with Ly-6C(hi) monocytosis. J. Am. Coll. Cardiol. 55:1629-1638. https ://doi.org /10.1016 /j.jacc.2009.08.089
30. Parissis, J.T., S. Adamopoulos, K.F. Venetsanou, D.G. Mentzikof, S.M. Karas, and D.T. Kremastinos. 2000. Clinical and neurohormonal correlates of circulating granulocyte-macrophage colony-stimulating factor in severe heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am. J. Cardiol. 86:707-710. https ://doi.org /10.1016 / S0002-9149(00)01062-6
31. Parissis, J.T., S. Adamopoulos, K. Venetsanou, G. Kostakis, A. Rigas, S.M. Karas, and D. Kremastinos. 2004. Plasma profiles of circulating granulocyte-macrophage colony-stimulating factor and soluble cellular adhesion molecules in acute myocardial infarction. Contribution to post-infarction left ventricular dysfunction. Eur. Cytokine Netw. 15:139-144
32. Pietras, E.M., D. Reynaud, Y.A. Kang, D. Carlin, F.J. Calero-Nieto, A.D. Leavitt, J.M. Stuart, B. Gottgens, and E. Passegue. 2015. Functionally Distinct Subsets of Lineage-Biased Multipotent Progenitors Control Blood Production in Normal and Regenerative Conditions. Cell Stem Cell. 17:35-46. https ://doi.org /10.1016 /j.stem.2015.05.003
33. Pinto, A.R., A. Ilinykh, M.J. Ivey, J.T. Kuwabara, M.L. D'Antoni, R. Debuque, A. Chandran, L. Wang, K. Arora, N.A. Rosenthal, and M.D. Tallquist. 2016. Revisiting Cardiac Cellular Composition. Circ. Res. 118:400-409. https ://doi.org /10.1161 /CIR CRE SAHA.115.307778
34. Prabhu, S.D., and N.G. Frangogiannis. 2016. The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis. Circ. Res. 119:91-112. https ://doi.org /10.1161 /CIR CRE SAHA.116.303577
35. Rauch, P.J., A. Chudnovskiy, C.S. Robbins, G.F. Weber, M. Etzrodt, I. Hilgendorf, E. Tiglao, J.L. Figueiredo, Y. Iwamoto, I. Theurl, et al. 2012. Innate response activator B cells protect against microbial sepsis. Science. 335:597-601. https ://doi.org /10.1126 /science.1215173
36. Robbins, C.S., I. Hilgendorf, G.F. Weber, I. Theurl, Y. Iwamoto, J.L. Figueiredo, R. Gorbatov, G.K. Sukhova, L.M. Gerhardt, D. Smyth, et al. 2013. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19:1166-1172. https ://doi.org /10.1038 / nm.3258
37. Romson, J.L., B.G. Hook, S.L. Kunkel, G.D. Abrams, M.A. Schork, and B.R. Lucchesi. 1983. Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation. 67:1016-1023. https :// doi.org /10.1161 /01.CIR.67.5.1016
38. Sager, H.B., T. Heidt, M. Hulsmans, P. Dutta, G. Courties, M. Sebas, G.R. Wojtkiewicz, B. Tricot, Y. Iwamoto, Y. Sun, et al. 2015. Targeting Interleukin-1beta Reduces Leukocyte Production After Acute Myocardial Infarction. Circulation. 132:1880-1890. https ://doi.org /10.1161 /CIR CUL ATI ONA HA.115.016160
39. Seiler, C., T. Pohl, K. Wustmann, D. Hutter, P.A. Nicolet, S. Windecker, F.R. Eberli, and B. Meier. 2001. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation. 104:2012-2017. https ://doi.org /10.1161 /hc4201.097835
40. Soehnlein, O., and L. Lindbom. 2010. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10:427-439. https ://doi.org /10.1038 /nri2779
41. Stock, A.T., J.A. Hansen, M.A. Sleeman, B.S. McKenzie, and I.P. Wicks. 2016. GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease. J. Exp. Med. 213:1983-1998. https ://doi.org /10.1084 /jem.20151853
42. Subramanian, M., E. Thorp, and I. Tabas. 2015. Identification of a nongrowth factor role for GM-CSF in advanced atherosclerosis: promotion of macrophage apoptosis and plaque necrosis through IL-23 signaling. Circ. Res. 116:e13-e24. https ://doi.org /10.1161 /CIR CRE SAHA.116.304794
43. Swirski, F.K., and M. Nahrendorf. 2013. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 339:161-166. https ://doi.org /10.1126 /science.1230719
44. Swirski, F.K., P. Libby, E. Aikawa, P. Alcaide, F.W. Luscinskas, R. Weissleder, and M.J. Pittet. 2007. Ly-6Chi monocytes dominate hypercholesterolemiaassociated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117:195-205. https ://doi.org /10.1172 /JCI29950
45. Swirski, F.K., M. Nahrendorf, M. Etzrodt, M. Wildgruber, V. Cortez-Retamozo, P. Panizzi, J.L. Figueiredo, R.H. Kohler, A. Chudnovskiy, P. Waterman, et al. 2009. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 325:612-616. https :// doi.org /10.1126 /science.1175202
46. Theurl, I., I. Hilgendorf, M. Nairz, P. Tymoszuk, D. Haschka, M. Asshoff, S. He, L.M. Gerhardt, T.A. Holderried, M. Seifert, et al. 2016. On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat. Med. 22:945-951. https ://doi.org /10.1038 /nm.4146
47. Tsujioka, H., T. Imanishi, H. Ikejima, A. Kuroi, S. Takarada, T. Tanimoto, H. Kitabata, K. Okochi, Y. Arita, K. Ishibashi, et al. 2009. Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction. J. Am. Coll. Cardiol. 54:130-138. https ://doi.org /10.1016 /j.jacc.2009.04.021
48. Weber, G.F., B.G. Chousterman, I. Hilgendorf, C.S. Robbins, I. Theurl, L.M. Gerhardt, Y. Iwamoto, T.D. Quach, M. Ali, J.W. Chen, et al. 2014. Pleural innate response activator B cells protect against pneumonia via a GMCSF-IgM axis. J. Exp. Med. 211:1243-1256. https ://doi.org /10.1084 / jem.20131471
49. Wicks, I.P., and A.W. Roberts. 2016. Targeting GM-CSF in inflammatory diseases. Nat. Rev. Rheumatol. 12:37-48. https ://doi.org /10.1038 / nrrheum.2015.161
50. Wu, L., S. Ong, M.V. Talor, J.G. Barin, G.C. Baldeviano, D.A. Kass, D. Bedja, H. Zhang, A. Sheikh, J.B. Margolick, et al. 2014. Cardiac fibroblasts mediate IL-17A-driven inflammatory dilated cardiomyopathy. J. Exp. Med. 211:1449-1464. https ://doi.org /10.1084 /jem.20132126